Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Victoria Biomedical Research Institute (VBRI) is a specialized clinical research organization and trial site located in Victoria, British Columbia, Canada. Founded in 2005, the institute focuses on the execution of Phase II through Phase IV clinical trials for international pharmaceutical and biotechnology sponsors. VBRI's core expertise lies in therapeutic areas such as cardiology, endocrinology, and respiratory medicine, where it manages patient recruitment and protocol implementation. The facility is equipped to handle high-complexity studies, providing the infrastructure necessary for rigorous clinical data collection. As a dedicated research site, VBRI plays a critical role in the late-stage development and regulatory approval process for new medical therapies. The institute is recognized for its high standards of patient care and data integrity within the clinical trial ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Victoria Biomedical Research Institute.